GE HealthCare Technologies Inc. has announced three additions to its Vivid cardiovascular ultrasound portfolio—Vivid Explorer, Vivid Advanced, and Vivid Focus—designed to support cardiac imaging across different care settings, showcased at the European Society of Cardiology Congress 2026 in Munich. The new systems, built on the same technology foundation as Vivid Pioneer, aim to address the distinct needs of echo labs, cardiology practices, and interventional settings while delivering a consistent user experience. Vivid Explorer targets high-volume echo labs with 4D and AI features, Vivid Advanced serves mid-size hospitals with comprehensive imaging, and Vivid Focus brings cSound technology to everyday cardiac imaging. The portfolio also includes the portable Vivid iq, and all systems feature AI-enabled tools like AI Auto Measure 2D and Easy AutoEF to simplify cardiac measurements. GE HealthCare also introduced EchoPAC Software Only v211 for remote or on-site review, with CE Mark received and FDA clearance pending. The global cardiovascular ultrasound market is projected to reach $3.40 billion in 2026, growing at a CAGR of 4.7% through 2033, driven by rising cardiovascular disease prevalence and demand for non-invasive diagnostics. GEHC stock has fallen 1% since the announcement and is down 12.6% year to date, while the S&P 500 has risen 12.2%.
GE HealthCare Technologies Inc.Launches three new Vivid cardiac ultrasound systems with AI features, expanding portfolio.
Veracyte Inc
West Pharmaceutical Services Inc
Globus Medical
